- Tytuł:
- Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
- Autorzy:
- Źródło:
- In Journal of Hepatology September 2022 77(3):607-618
Czasopismo naukowe